TechWald Holding

Venture Capital Active Milano, Italy Est. 2017
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
5
in our dataset
Rounds participated
7
Rounds led
0
Rounds' value
$89.5M
total disclosed, rounds participated
Stages
A Round, C Round, Pre-Seed, D Round, G Round, F Round, Seed, E Round, B Round

About

TechWald Holding S.p.A. has relevant expertise in supporting the growth of potential early stage companies committed to develop healthcare innovation with a focus on MedTech Industry and Medical Technologies.

The Company’s purpose is the performance of services and managerial activities for the strategic orientation, development, support, coordination and management of shareholdings acquired as stable equity investments in the sector of HealthCare/MedTech – Pharma/Biotech

Portfolio · 5

NitiNotes
Robotic Endoscopic Suturing
3 rounds $22.8M committed Latest: 2024-12
ValCare Medical
Minimally Invasive Treatment for Valve Disease
1 round Latest: 2023-11
SoniVie
Pulmonary Hypertension Denervation Treatment
1 round $60.0M committed Latest: 2023-01
Beyeonics
Surgical Visualization Technologies
1 round Latest: 2021-10
Bendit
Miniaturized Vascular Navigation
1 round $6.8M committed Latest: 2017-08

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences5

Q&A

What is TechWald Holding's primary investment focus?
TechWald Holding specializes in supporting the growth of early-stage companies focused on healthcare innovation, particularly within the MedTech Industry and Medical Technologies.
When was TechWald Holding founded?
TechWald Holding was founded in 2017.
Which key personnel are part of TechWald Holding's leadership?
Key personnel at TechWald Holding include Massimo Prelz as Chairman of the Board of Directors, Alessandro Piga as Co-founder & Managing Director, and Doron Cohen as Managing Partner.
Can you name some of TechWald Holding's portfolio companies?
TechWald Holding's portfolio includes companies such as Bendit, which focuses on miniaturized vascular navigation, and Beyeonics, specializing in surgical visualization technologies.
Has TechWald Holding had any notable exits?
Yes, SoniVie, a portfolio company focused on pulmonary hypertension denervation treatment, was acquired by Boston Scientific in March 2025 for $400 million.
What investment stages does TechWald Holding typically participate in?
TechWald Holding participates in a range of investment stages, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
What is the geographic focus of TechWald Holding?
TechWald Holding is headquartered in Milano, Italy.
What is TechWald Holding's investment range?
TechWald Holding's investment range is between $6.4 million and $60 million.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)